Benzodiazepine derivatives

This invention provides benzodiazepine derivatives of the general formula wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FISCHLI, ALBERT E, SZENTE, ANDRE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FISCHLI
ALBERT E
SZENTE
ANDRE
description This invention provides benzodiazepine derivatives of the general formula wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alkyl group and R6 represents a lower alkyl, lower hydroxyalkyl or lower acyloxyalkyl group or R5 represents a hydrogen atom and R6 represents an aryl or lower aralkyl group or R5 and R6 together with the nitrogen atom to which they are attached represent a 3-membered to 7-membered heterocycle which, when it is at least 5-membered, can contain as a ring member an oxygen or sulphur atom or a group of the formula in which R7 represents a hydrogen atom or a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof, which possess aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, of hepatic ascites, of primary aldosteronism and of idiopathic hypertension. Some of these compounds and salts also inhibit the intestinal resorption of cholesterol and are according suitable for the prevention or control of atherosclerosis. Also provided are a process for the manufacture of the above end products and novel intermediates therefor.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US4299767A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US4299767A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US4299767A3</originalsourceid><addsrcrecordid>eNrjZJBySs2ryk_JTKxKLcjMS1VISS3KLEssySxLLeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfGhwSZGlpbmZuaOxoRVAAD7VyMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Benzodiazepine derivatives</title><source>esp@cenet</source><creator>FISCHLI; ALBERT E ; SZENTE; ANDRE</creator><creatorcontrib>FISCHLI; ALBERT E ; SZENTE; ANDRE</creatorcontrib><description>This invention provides benzodiazepine derivatives of the general formula wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alkyl group and R6 represents a lower alkyl, lower hydroxyalkyl or lower acyloxyalkyl group or R5 represents a hydrogen atom and R6 represents an aryl or lower aralkyl group or R5 and R6 together with the nitrogen atom to which they are attached represent a 3-membered to 7-membered heterocycle which, when it is at least 5-membered, can contain as a ring member an oxygen or sulphur atom or a group of the formula in which R7 represents a hydrogen atom or a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof, which possess aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, of hepatic ascites, of primary aldosteronism and of idiopathic hypertension. Some of these compounds and salts also inhibit the intestinal resorption of cholesterol and are according suitable for the prevention or control of atherosclerosis. Also provided are a process for the manufacture of the above end products and novel intermediates therefor.</description><edition>3</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1981</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19811110&amp;DB=EPODOC&amp;CC=US&amp;NR=4299767A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19811110&amp;DB=EPODOC&amp;CC=US&amp;NR=4299767A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FISCHLI; ALBERT E</creatorcontrib><creatorcontrib>SZENTE; ANDRE</creatorcontrib><title>Benzodiazepine derivatives</title><description>This invention provides benzodiazepine derivatives of the general formula wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alkyl group and R6 represents a lower alkyl, lower hydroxyalkyl or lower acyloxyalkyl group or R5 represents a hydrogen atom and R6 represents an aryl or lower aralkyl group or R5 and R6 together with the nitrogen atom to which they are attached represent a 3-membered to 7-membered heterocycle which, when it is at least 5-membered, can contain as a ring member an oxygen or sulphur atom or a group of the formula in which R7 represents a hydrogen atom or a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof, which possess aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, of hepatic ascites, of primary aldosteronism and of idiopathic hypertension. Some of these compounds and salts also inhibit the intestinal resorption of cholesterol and are according suitable for the prevention or control of atherosclerosis. Also provided are a process for the manufacture of the above end products and novel intermediates therefor.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1981</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBySs2ryk_JTKxKLcjMS1VISS3KLEssySxLLeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfGhwSZGlpbmZuaOxoRVAAD7VyMA</recordid><startdate>19811110</startdate><enddate>19811110</enddate><creator>FISCHLI; ALBERT E</creator><creator>SZENTE; ANDRE</creator><scope>EVB</scope></search><sort><creationdate>19811110</creationdate><title>Benzodiazepine derivatives</title><author>FISCHLI; ALBERT E ; SZENTE; ANDRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US4299767A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1981</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>FISCHLI; ALBERT E</creatorcontrib><creatorcontrib>SZENTE; ANDRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FISCHLI; ALBERT E</au><au>SZENTE; ANDRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Benzodiazepine derivatives</title><date>1981-11-10</date><risdate>1981</risdate><abstract>This invention provides benzodiazepine derivatives of the general formula wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alkyl group and R6 represents a lower alkyl, lower hydroxyalkyl or lower acyloxyalkyl group or R5 represents a hydrogen atom and R6 represents an aryl or lower aralkyl group or R5 and R6 together with the nitrogen atom to which they are attached represent a 3-membered to 7-membered heterocycle which, when it is at least 5-membered, can contain as a ring member an oxygen or sulphur atom or a group of the formula in which R7 represents a hydrogen atom or a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof, which possess aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, of hepatic ascites, of primary aldosteronism and of idiopathic hypertension. Some of these compounds and salts also inhibit the intestinal resorption of cholesterol and are according suitable for the prevention or control of atherosclerosis. Also provided are a process for the manufacture of the above end products and novel intermediates therefor.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US4299767A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Benzodiazepine derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T10%3A49%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FISCHLI;%20ALBERT%20E&rft.date=1981-11-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS4299767A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true